image: This is Andrew Adey, PhD, recipient of ASHG's 2018 Early-Career Award. view more
Credit: Andrew Adey
ROCKVILLE, MD - The American Society of Human Genetics (ASHG) has named Andrew Adey, PhD, as the recipient of the 2018 Early-Career Award. Dr. Adey is an Assistant Professor for the Department of Molecular & Medical Genetics within the School of Medicine at Oregon Health & Science University (OHSU).
This award recognizes the contributions of genetics and genomics scientists in the first ten years of their careers as independent investigators. ASHG will present the award, which will include a plaque and $10,000 prize, on Friday, October 19, during the organization's 68th Annual Meeting in San Diego, California.
"In a relatively short time, Dr. Adey's research has made an impressive impact on the scientific understanding of cancer development, progression, and response to treatment," said David L. Nelson, PhD, President of ASHG. "We expect his contributions to the genetics community to continue to grow and advance the field."
Dr. Adey's research focuses on the next technical frontier of genomic and epigenetic profiling at a massive scale. Immediately after completing his PhD in Molecular & Cellular Biology, Dr. Adey joined the faculty at OHSU to form his independent research group. Along with his team, he established novel single-cell technologies, including methods to profile thousands of single-cell genomes and epigenomes rapidly and cheaply. This single-cell platform is useful in showing epigenomic changes that enable early cancer progression or that influence response to therapeutic intervention in advanced cancers. His methods are already being used worldwide to better understand the epigenetics of development in both healthy controls and disease models.
A member of ASHG since 2012, Dr. Adey has received several awards for his work, including the University of Washington Distinguished Dissertation Award and the Harold M. Weintraub Graduate Student Award, both in 2014. He also received the highly competitive National Institutes of Health/NIGMS R35 Grant in 2017.
###